Emerging Biosensing Technologies for Neuroinflammatory and Neurodegenerative Disease Diagnostics.

about

Emerging Biosensing Technologies for Neuroinflammatory and Neurodegenerative Disease Diagnostics.

Item

http://www.wikidata.org/entity/Q55379242

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Emerging Biosensing Technologi ...... enerative Disease Diagnostics.

@en

Emerging Biosensing Technologi ...... enerative Disease Diagnostics.

@nl

type

Item

label

Emerging Biosensing Technologi ...... enerative Disease Diagnostics.

@en

Emerging Biosensing Technologi ...... enerative Disease Diagnostics.

@nl

prefLabel

Emerging Biosensing Technologi ...... enerative Disease Diagnostics.

@en

Emerging Biosensing Technologi ...... enerative Disease Diagnostics.

@nl

P1476

Emerging Biosensing Technologi ...... enerative Disease Diagnostics.

@en

P2093

Joana Guimarães

http://www.w3.org/2001/XMLSchema#string

Maria José Sá

http://www.w3.org/2001/XMLSchema#string

Ricardo Soares-Dos-Reis

http://www.w3.org/2001/XMLSchema#string

P2860

TREM2 Variants in Alzheimer's Disease

Apolipoprotein E, Dementia, and Cortical Deposition of β-Amyloid Protein

NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice

Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies

Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease

Imaging multiple sclerosis and other neurodegenerative diseases

Targeting neuroinflammation in Alzheimer's disease

Decrease of serum levels of the anti-inflammatory cytokine interleukin-10 in patients with advanced chronic heart failure

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

The cerebrospinal fluid cytokine signature of multiple sclerosis: a homogenous response that does not conform to the Th1/Th2/Th17 convention

P304

164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNMOL.2018.00164

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29867354

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

P932

5964192

http://www.w3.org/2001/XMLSchema#string